Bryan Koci

468 total citations
7 papers, 300 citations indexed

About

Bryan Koci is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bryan Koci has authored 7 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bryan Koci's work include Cardiac electrophysiology and arrhythmias (3 papers), Ion channel regulation and function (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Bryan Koci is often cited by papers focused on Cardiac electrophysiology and arrhythmias (3 papers), Ion channel regulation and function (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Bryan Koci collaborates with scholars based in United States. Bryan Koci's co-authors include Walter A. Volberg, Wei-guo Su, Jun Zhou, Jun Zhou, Jenifer A. Bradley, Xian Chen, Zhuoqian Sun, Jason Cordes, Corinne E. Augelli‐Szafran and Brian L. Knight and has published in prestigious journals such as Circulation, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

Bryan Koci

7 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan Koci United States 5 220 215 55 24 21 7 300
Gan-Xin Yan United States 4 553 2.5× 812 3.8× 53 1.0× 20 0.8× 23 1.1× 4 835
Charles M. Pearman United Kingdom 10 131 0.6× 316 1.5× 30 0.5× 12 0.5× 40 1.9× 25 403
Hiro Matsui United States 4 292 1.3× 318 1.5× 47 0.9× 11 0.5× 26 1.2× 5 615
Udin Bahrudin Indonesia 10 166 0.8× 132 0.6× 27 0.5× 38 1.6× 19 0.9× 41 337
Chia-Tung Wu Taiwan 8 141 0.6× 240 1.1× 19 0.3× 8 0.3× 41 2.0× 26 369
M. Boulaksil Netherlands 10 166 0.8× 243 1.1× 25 0.5× 5 0.2× 25 1.2× 21 318
J Senges Germany 11 125 0.6× 325 1.5× 20 0.4× 17 0.7× 26 1.2× 35 385
Yayoi Tsuneoka Japan 14 153 0.7× 245 1.1× 25 0.5× 6 0.3× 7 0.3× 27 335
Slawomir Weretka Germany 12 74 0.3× 357 1.7× 35 0.6× 3 0.1× 28 1.3× 22 399

Countries citing papers authored by Bryan Koci

Since Specialization
Citations

This map shows the geographic impact of Bryan Koci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Koci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Koci more than expected).

Fields of papers citing papers by Bryan Koci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Koci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Koci. The network helps show where Bryan Koci may publish in the future.

Co-authorship network of co-authors of Bryan Koci

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Koci. A scholar is included among the top collaborators of Bryan Koci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Koci. Bryan Koci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Dellos-Nolan, Sheri, Bryan Koci, Judith C. Gallucci, et al.. (2020). Novel bacterial topoisomerase inhibitors derived from isomannide. European Journal of Medicinal Chemistry. 199. 112324–112324. 8 indexed citations
2.
Koci, Bryan, et al.. (2019). Optimization of cardiac CiPA targets (hCav1.2 and hKCNQ1/hminK) on the QPatch HT automated system. Journal of Pharmacological and Toxicological Methods. 99. 106595–106595. 1 indexed citations
3.
Renganathan, Muthukrishnan, et al.. (2019). Automated high-throughput Na+ late current assay in QPatch HT platform for CiPA28. Journal of Pharmacological and Toxicological Methods. 99. 106595–106595. 1 indexed citations
4.
Koci, Bryan, Gregory C. Luerman, Ralf Kettenhofen, et al.. (2017). An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities. Toxicology and Applied Pharmacology. 329. 121–127. 28 indexed citations
5.
Zhou, Jun, Corinne E. Augelli‐Szafran, Jenifer A. Bradley, et al.. (2005). Novel Potent Human Ether-à-Go-Go-Related Gene (hERG) Potassium Channel Enhancers and Their in Vitro Antiarrhythmic Activity. Molecular Pharmacology. 68(3). 876–884. 110 indexed citations
6.
Volberg, Walter A., et al.. (2002). Blockade of Human Cardiac Potassium Channel Human Ether-a-go-go-Related Gene (HERG) by Macrolide Antibiotics. Journal of Pharmacology and Experimental Therapeutics. 302(1). 320–327. 124 indexed citations
7.
Villanueva, Flordeliza S., Judith A. Abraham, George F. Schreiner, et al.. (2002). Myocardial Contrast Echocardiography Can Be Used to Assess the Microvascular Response to Vascular Endothelial Growth Factor-121. Circulation. 105(6). 759–765. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026